Hypoxia induces proliferation via NOX4-Mediated oxidative stress and TGF-β3 signaling in uterine leiomyoma cells

References

• Lewis TD, Malik M, Britten J, et al. A comprehensive review of the pharmacologic management of uterine leiomyoma. Biomed Res Int. 2018;2018:2414609.
   PubMed Web of Science ®Google Scholar
• Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107.
   PubMed Web of Science ®Google Scholar
• Mayer A, Höckel M, Wree A, et al. Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res. 2008;68(12):4719–4726.
   PubMed Web of Science ®Google Scholar
• Fruehauf JP, Meyskens FL. Jr., Reactive oxygen species: a breath of life or death? Clin Cancer Res. 2007;13(3):789–794.
   PubMed Web of Science ®Google Scholar
• Clanton TL. Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol. 2007;102(6):2379–2388.
   PubMed Web of Science ®Google Scholar
• Knock GA. NADPH oxidase in the vasculature: expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension. Free Radic Biol Med. 2019;145:385–427.
   PubMed Web of Science ®Google Scholar
• Fletcher NM, Abusamaan MS, Memaj I, et al. Oxidative stress: a key regulator of leiomyoma cell survival. Fertil Steril. 2017;107(6):1387–1394.e1381.
   PubMed Web of Science ®Google Scholar
• Fletcher NM, Saed MG, Abuanzeh S, et al. Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma. Reprod Sci. 2014;21(9):1145–1152.
   PubMed Web of Science ®Google Scholar
• Luo X, Ding L, Xu J, et al. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology. 2005;146(3):1097–1118.
   PubMed Web of Science ®Google Scholar
• Malik M, Catherino WH. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays. Fertil Steril. 2007;87(5):1166–1172.
   PubMed Web of Science ®Google Scholar
• Arici A, Sozen I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril. 2000;73(5):1006–1011.
   PubMed Web of Science ®Google Scholar
• Borahay MA, Al-Hendy A, Kilic GS, et al. Signaling pathways in leiomyoma: Understanding pathobiology and implications for therapy. Mol Med. 2015a;21(1):242–256.
   PubMedGoogle Scholar
• Lee BS, Nowak RA. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. J Clin Endocrinol Metab. 2001;86(2):913–920.
   PubMed Web of Science ®Google Scholar
• Massagué J, Wotton D. Transcriptional control by the TGF-beta/smad signaling system. Embo j. 2000;19(8):1745–1754.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang HM, Liu CF, et al. TGF-β3 induces autophagic activity by increasing ROS generation in a NOX4-Dependent pathway. Mediators Inflamm. 2019;2019:3153240.
   PubMed Web of Science ®Google Scholar
• Afrin S, El Sabeh M, Islam MS, et al. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation. Pharmacol Res. 2021;172:105856.
   PubMed Web of Science ®Google Scholar
• Afrin S, Islam MS, Patzkowsky K, et al. Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells. Am J Obstet Gynecol. 2020;223(5):733.e731–733.e714.
   Web of Science ®Google Scholar
• Borahay MA, Kilic GS, Yallampalli C, et al. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells. J Biol Chem. 2014;289(51):35075–35086.
   PubMed Web of Science ®Google Scholar
• El Sabeh M, Saha SK, Afrin S, et al. Simvastatin inhibits Wnt/beta-catenin pathway in uterine leiomyoma. Endocrinology. 2021;162(12):bqab211.
   PubMed Web of Science ®Google Scholar
• Borahay MA, Vincent K, Motamedi M, et al. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015;213(2):196.e191–198.
   Web of Science ®Google Scholar
• Moon YM, Kang HJ, Cho JS, et al. Nox4 mediates hypoxia-stimulated myofibroblast differentiation in nasal polyp-derived fibroblasts. Int Arch Allergy Immunol. 2012;159(4):399–409.
   PubMed Web of Science ®Google Scholar
• Nishi H, Nakada T, Hokamura M, et al. Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast. Endocrinology. 2004;145(9):4113–4118.
   PubMed Web of Science ®Google Scholar
• Zhou G, Dada LA, Wu M, et al. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol. 2009;297(6):L1120–1130.
   PubMed Web of Science ®Google Scholar
• Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96(4):E754–E762.
   PubMed Web of Science ®Google Scholar
• Chen J, Khalil RA. Matrix metalloproteinases in normal pregnancy and preeclampsia. Prog Mol Biol Transl Sci. 2017;148:87–165.
   PubMed Web of Science ®Google Scholar
• Norian JM, Malik M, Parker CY, et al. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci. 2009;16(12):1153–1164.
   PubMed Web of Science ®Google Scholar
• Salama SA, Diaz-Arrastia CR, Kilic GS, et al. 2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells . Fertil Steril. 2012;98(1):178–184.
   PubMed Web of Science ®Google Scholar
• Mallikarjuna P, Raviprakash TS, Aripaka K, et al. Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma. Cell Cycle. 2019;18(17):2141–2156.
   PubMed Web of Science ®Google Scholar
• McMahon S, Charbonneau M, Grandmont S, et al. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem. 2006;281(34):24171–24181.
   PubMed Web of Science ®Google Scholar
• Borahay MA, Vincent KL, Motamedi M, et al. Liposomal 2-Methoxyestradiol nanoparticles for treatment of uterine leiomyoma in a Patient-Derived xenograft mouse model. Reprod Sci. 2021;28(1):271–277.
   PubMed Web of Science ®Google Scholar